Erratum to: Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis (CNS Drugs, 10.1007/s40263-017-0433-0)

Gali Pariente; Tom Leibson; Talya Shulman; Thomasin Adams-Webber; Eran Barzilay; Irena Nulman

doi:10.1007/s40263-017-0439-7

Erratum to: Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis (CNS Drugs, 10.1007/s40263-017-0433-0)

Gali Pariente, Tom Leibson, Talya Shulman, Thomasin Adams-Webber, Eran Barzilay, Irena Nulman

Research output: Contribution to journal › Comment/debate

2 Scopus citations

Abstract

An Online First version of this article was made available online at http://link.springer.com/journal/40263/ onlineFirst/page/1 on 22 April 2017. An error was subsequently identified in the article, and the following correction should be noted: Page 1, abstract, column 2, lines 2–6: The following sentence, which previously read: “… in utero exposure to lamotrigine monotherapy was found to be associated with significantly decreased rates of inborn defects (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.62–2.16 and OR 1.25; 95% CI 0.89–1.74, respectively).” should read: “… in utero exposure to lamotrigine monotherapy was not found to be associated with significantly increased rates of inborn defects (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.62–2.16 and OR 1.25; 95% CI 0.89–1.74, respectively).”.

Original language	English
Pages (from-to)	451
Number of pages	1
Journal	CNS Drugs
Volume	31
Issue number	6
DOIs	https://doi.org/10.1007/s40263-017-0439-7
State	Published - 1 Jun 2017
Externally published	Yes

ASJC Scopus subject areas

Clinical Neurology
Psychiatry and Mental health
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s40263-017-0439-7

Cite this

@article{aa6b55396bd54376b227789f920daf2c,

title = "Erratum to: Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis (CNS Drugs, 10.1007/s40263-017-0433-0)",

abstract = "An Online First version of this article was made available online at http://link.springer.com/journal/40263/ onlineFirst/page/1 on 22 April 2017. An error was subsequently identified in the article, and the following correction should be noted: Page 1, abstract, column 2, lines 2–6: The following sentence, which previously read: “… in utero exposure to lamotrigine monotherapy was found to be associated with significantly decreased rates of inborn defects (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.62–2.16 and OR 1.25; 95% CI 0.89–1.74, respectively).” should read: “… in utero exposure to lamotrigine monotherapy was not found to be associated with significantly increased rates of inborn defects (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.62–2.16 and OR 1.25; 95% CI 0.89–1.74, respectively).”.",

author = "Gali Pariente and Tom Leibson and Talya Shulman and Thomasin Adams-Webber and Eran Barzilay and Irena Nulman",

note = "Publisher Copyright: {\textcopyright} 2017, Springer International Publishing Switzerland.",

year = "2017",

month = jun,

day = "1",

doi = "10.1007/s40263-017-0439-7",

language = "English",

volume = "31",

pages = "451",

journal = "CNS Drugs",

issn = "1172-7047",

publisher = "Adis International Ltd",

number = "6",

}

TY - JOUR

T1 - Erratum to

T2 - Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis (CNS Drugs, 10.1007/s40263-017-0433-0)

AU - Pariente, Gali

AU - Leibson, Tom

AU - Shulman, Talya

AU - Adams-Webber, Thomasin

AU - Barzilay, Eran

AU - Nulman, Irena

PY - 2017/6/1

Y1 - 2017/6/1

N2 - An Online First version of this article was made available online at http://link.springer.com/journal/40263/ onlineFirst/page/1 on 22 April 2017. An error was subsequently identified in the article, and the following correction should be noted: Page 1, abstract, column 2, lines 2–6: The following sentence, which previously read: “… in utero exposure to lamotrigine monotherapy was found to be associated with significantly decreased rates of inborn defects (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.62–2.16 and OR 1.25; 95% CI 0.89–1.74, respectively).” should read: “… in utero exposure to lamotrigine monotherapy was not found to be associated with significantly increased rates of inborn defects (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.62–2.16 and OR 1.25; 95% CI 0.89–1.74, respectively).”.

AB - An Online First version of this article was made available online at http://link.springer.com/journal/40263/ onlineFirst/page/1 on 22 April 2017. An error was subsequently identified in the article, and the following correction should be noted: Page 1, abstract, column 2, lines 2–6: The following sentence, which previously read: “… in utero exposure to lamotrigine monotherapy was found to be associated with significantly decreased rates of inborn defects (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.62–2.16 and OR 1.25; 95% CI 0.89–1.74, respectively).” should read: “… in utero exposure to lamotrigine monotherapy was not found to be associated with significantly increased rates of inborn defects (odds ratio [OR] 1.15; 95% confidence interval [CI] 0.62–2.16 and OR 1.25; 95% CI 0.89–1.74, respectively).”.

UR - http://www.scopus.com/inward/record.url?scp=85019240546&partnerID=8YFLogxK

U2 - 10.1007/s40263-017-0439-7

DO - 10.1007/s40263-017-0439-7

M3 - Comment/debate

C2 - 28512694

AN - SCOPUS:85019240546

SN - 1172-7047

VL - 31

SP - 451

JO - CNS Drugs

JF - CNS Drugs

IS - 6

ER -

Erratum to: Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis (CNS Drugs, 10.1007/s40263-017-0433-0)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this